Press Release
April 6, 2018

Life Sciences Partner Julie Tibbets Pens Monthly Column for PM360 on Timely Product Marketing Regulatory Developments


FDA partner Julie Tibbets shares insights on regulatory developments and trends in drug and device marketing and product communications strategies with PM360. Tibbets’ most recent articles include:

Tibbets focuses her practice on FDA-regulated product development, marketing and corporate communications as well as the intersection of each of those with corporate strategy and securities disclosure obligations. She also advises clients on interactions with the FDA, product formulations, clinical trial documentation, adverse event reporting, commercial strategy, product labeling and advertising. Since 2016, Tibbets has been listed in The Best Lawyers in America for FDA law.

PM360 provides timely, credible and actionable pharma marketing “how tos” that inform and help guide product managers and pharma marketing professionals to succeed in the complex and highly regulated medical product environment.